Form 4: Oscar Health President's Equity Transactions
Insider Transaction Report
Oscar Health President Janet Liang reported the acquisition of restricted stock units and the sale of shares to cover tax obligations.
Summary
- Janet Liang, President of Oscar Insurance, acquired 106,458 Class A Common Stock shares in the form of restricted stock units (RSUs) on March 2, 2026.
- These RSUs will vest quarterly in 12 equal installments, beginning on June 1, 2026, contingent on continuous service.
- Liang also disposed of 7,453 Class A Common Stock shares on March 2, 2026, at a weighted average price of $13.39 per share.
- The sale was executed under a Rule 10b5-1 plan established on August 8, 2025, specifically to satisfy tax withholding obligations related to previously granted equity awards.
- Following these transactions, Liang's direct beneficial ownership of Class A Common Stock stands at 271,532 shares.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as neutral to slightly positive. The acquisition of RSUs demonstrates continued executive alignment, while the sale for tax purposes is a standard, non-discretionary event.
Positives
- The acquisition of 106,458 restricted stock units aligns management's long-term interests with those of shareholders, indicating continued commitment to the company's performance.
Negatives
- The disposition of 7,453 shares, even for tax purposes, represents a reduction in the reporting person's direct equity holdings.
Future Outlook
The acquired restricted stock units are scheduled to vest quarterly in 12 equal installments, commencing on June 1, 2026, subject to the reporting person's continued employment.
Management Comments
- The sale of shares was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025, to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
Industry Context
StockSavvy.ai notes that Form 4 filings detailing insider transactions, such as the acquisition of restricted stock units and sales for tax obligations, are routine occurrences for executives in publicly traded companies. These transactions are typically part of pre-arranged compensation and tax planning strategies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The sale of shares was conducted under a Rule 10b5-1 instruction letter, indicating adherence to insider trading policies and pre-planned transactions to avoid accusations of trading on material non-public information. | August 8, 2025 | Enhances transparency and reduces potential for insider trading concerns by pre-scheduling equity dispositions. |
Stakeholder Impact
- Shareholders: The acquisition of RSUs by a key executive generally signals continued commitment and aligns executive incentives with shareholder value creation. The sale for tax purposes is a routine event with minimal impact.
- Employees: The vesting schedule of RSUs is a standard component of executive compensation, potentially influencing employee morale and retention through similar incentive structures.
Next Steps
- The restricted stock units will begin vesting quarterly in 12 equal installments starting June 1, 2026.
Key Dates
| Date | Description |
|---|---|
| August 8, 2025 | Date Rule 10b5-1 instruction letter was entered into for the sale of shares. |
| March 2, 2026 | Date of both the acquisition of restricted stock units and the disposition of shares. |
| March 4, 2026 | Date the Form 4 filing was signed. |
| June 1, 2026 | Start date for the quarterly vesting of the acquired restricted stock units. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation and tax planning. It does not contain new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The acquisition of RSUs is a positive for long-term alignment, while the sale for tax is a non-discretionary event. Therefore, a 'hold' recommendation is appropriate as the filing does not alter the fundamental investment thesis for Oscar Health.
Keywords
Oscar Health, OSCR, Insider Transaction, Form 4, Restricted Stock Units, Equity Compensation, Rule 10b5-1 Plan, Janet Liang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.